Physicochemical properties of Rituximab

Journal of Liquid Chromatography and Related Technologies

Volumn 37, Issue 10, 2014, Pages 1438-1452

  Flores Ortiz, Luis F ^a   Campos García, Víctor R ^a   Perdomo Abúndez, Francisco C ^a   Pérez, Néstor O ^a   Medina Rivero, Emilio ^a  

^a Probiomed SA de CV   (Mexico)

Author keywords

Biosimilar; Charge variants; Comparability; Physicochemical properties; Rituximab; Stability

Indexed keywords

CHEMICAL ANALYSIS; CONVERGENCE OF NUMERICAL METHODS; LIQUID CHROMATOGRAPHY;

BIOSIMILAR; CHARGE VARIANTS; COMPARABILITY; PHYSICOCHEMICAL PROPERTY; RITUXIMAB;

MOLECULES;

GENERIC DRUG; KIKUZUBAM; RITUXIMAB; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; CONFORMATIONAL TRANSITION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG POTENCY; DRUG STABILITY; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 84896134428     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2013.794738     Document Type: Article

References (27)

1. Sinha, S.; Zhang, L.; Duan, S.; Williams, T. D.; Vlasak, J. Effect of Protein Structure on Deamidation Rate in the Fc Fragment of an IgG1 Monoclonal Antibody. Protein Sci. 2009, 18 (8), 1573-1584.
2. Liu, D.; Ren, D.; Huang, H.; Dankberg, J.; Rosenfeld, R. Structure and Stability Changes of Human IgG1 Fc as a Consequence of Methionine Oxidation. Biochem. 2008, 47 (18), 5088-5100. (Pubitemid 351620747)
3. Perkins, M.; Theiler, R.; Lunte, S.; Jeschke, M. Determination of the Origin of Charge Heterogeneity in a Murine Monoclonal Antibody. Pharm. Res. 2000, 17 (9), 1110-1117.
4. Raju, T. S.; Scallon, B. J. Glycosylation in the Fc Domain of IgG Increases Resistance to Proteolytic Cleavage by Papain. Biochem. Biophys. Res. Comm. 2006, 341 (3), 797-803. (Pubitemid 43177560)
5. Geyer, H.; Geyer R. Strategies for Analysis of Glycoprotein Glycosilation. Biochim. Biophys. Acta. 2006, 1764, 1853-1869.
6. Gadgil, H. S.; Bondarenko, P. V.; Pipes, G. D.; Dillon, T. M.; Banks, D. Identification of Cysteinylation of a Free Cysteine in the Fab Region of a Recombinant Monoclonal IgG1 Antibody Using Lys-C Limited Proteolysis Coupled with LC =MS Analysis. Anal. Biochem. 2006, 355 (2), 165-174. (Pubitemid 44107324)
7. Moorhouse, K. G.; Nashabeh, W.; Deveney, J.; Bjork, N. S.; Mulkerrin, M. G. Validation of an HPLC Method for the Analysis of the Charge Heterogeneity of the Recombinant Monoclonal Antibody IDEC-C2B8 After Papain Digestion. J. Pharm. Biomed. Anal. 1997, 16 (4), 593-603. (Pubitemid 28044191)
8. Wang, W. Protein Aggregation and Its Inhibition in Biopharmaceutics. Int. J. Pharm. 2005, 289 (1-2), 1-30. (Pubitemid 40093537)
9. Bajaj, H.; Sharma, V. K.; Badkar, A.; Zeng, D.; Nema, S. Protein Structural Conformation and Not Second Virial Coefficient Relates to Long-Term Irreversible Aggregation of a Monoclonal Antibody and Ovalbumin in Solution. Pharm. Res. 2006, 23 (6), 1382-1394. (Pubitemid 43946160)
10. Roberts, C. J. Non-Native Protein Aggregation Kinetics. Biotechnol. Bioeng. 2007, 98 (5), 927-938. (Pubitemid 350205571)
11. Rabe, M.; Verdes, D.; Seeger, S. Understanding Protein Adsorption Phenomena at Solid Surfaces. Adv. Colloid Interface Sci. 2011, 162 (1-2), 87-106.
12. Anderson, D. R.; Grillo-López, A.; Varns, C.; Chambers, K. S.; Hanna, N. Targeted Anti-Cancer Therapy Using Rituximab, a Chimaeric Anti-CD20 Antibody (IDEC-C2B8) in the Treatment of Non-Hodgkin's B-Cell Lymphoma. Biochem. Soc. Trans. 1997, 25 (2), 705-708. (Pubitemid 27260903)
13. Miyata, K.; Nakai, K.; Aso, H.; Kinoshita, H.; Kawanishi, T. Comparability Study in Humans of EPOCH Manufactured Under Serum-Free Conditions. Jap. J. Pharmacol. 2009, 37 (2), 95-107.
14. Falconer, R. J.; Jackson-Matthews, D.; Mahler, S. M. Analytical Strategies for Assessing Comparability of Biosimilars. J. Chem. Technol. Biotechnol. 2011, 86 (7), 915-922.
15. Hunt, G.; Moorhouse, K. G.; Chen, A. B. Capillary Isoelectric Focusing and Sodium Dodecyl Sulfate-Capillary Gel Electrophoresis of Recombinant Humanized Monoclonal Antibody HER2. J. Chromatogr. A 1996, 744 (1-2), 295-301. (Pubitemid 26319708)
16. Lazar, G. A.; Dang, W.; Karki, S.; Vafa, O.; Peng, J. E. Engineered antibody Fc variants with enhanced effector function. Proceedings of the National Academy of Sciences of the United States of America 103(11):4005-4010.
17. Schiestl, M.; Stangler, T.; Torella, C.; Čepeljnik, T.; Toll, H. 2011. Acceptable Changes in Quality Attributes of Glycosylated Biopharmaceuticals. Nature Biotechnol. 2006, 29 (4), 310-312.
18. Manzke, O.; Tesch, H.; Diehl, V.; Bohlen, H. Single-Step Purification of Bispecific Monoclonal Antibodies for Immunotherapeutic Use by Hydrophobic Interaction Chromatography. J. Immunol. Method. 1997, 208 (1), 65-73. (Pubitemid 28018370)
19. Gandhi, S.; Ren, D.; Xiao, G.; Bondarenko, P.; Sloey, C. Elucidation of Degradants in Acidic Peak of Cation Exchange Chromatography in an IgGI Monoclonal Antibody Formed on Long-Term Storage in a Liquid Formulation. Pharm. Res. 2012, 29 (1), 209-224.
20. Cai, B.; Pan, H.; Flynn, G. C. C-Terminal Lysine Processing of Human Immunoglobulin G2 Heavy Chain In Vivo. Biotechnol. Bioeng. 2011, 108 (2), 404-412.
21. Antes, B.; Amon, S.; Rizzi, A.; Wiederkum, S.; Kainer, M. Analysis of Lysine Clipping of a Humanized Lewis-Y Specific IgG Antibody and Its Relation to Fc-Mediated Effector Function. J. Chromatogr. B 2007, 852 (1-2), 250-256. (Pubitemid 46830116)
22. Dick, L. W.; Qiu, D.; Mahon, D.; Adamo, M.; Cheng, K. C. C-Terminal Lysine Variants in Fully Human Monoclonal Antibodies: Investigation of Test Methods and Possible Causes. Biotechnol. Bioeng. 2008, 100 (6), 1132-1143.
23. He, F.; Hogan, S.; Latypov, R. F.; Narhi, L. O.; Razinkov, V. I. High Throughput Thermostability Screening of Monoclonal Antibody Formulations. J. Pharm. Sci. 2010, 99 (4), 1707-1720.
24. Ionescu, R. M.; Vlasak, J.; Price, C.; Kirchmeier, M. Contribution of Variable Domains to the Stability of Humanized IgG1 Monoclonal Antibodies. J. Pharm. Sci. 2008, 97 (4), 1414-1426.
25. Andersen, C. B.; Manno, M.; Rischel, C.; Thórólfsson, M.; Martorana, V. Aggregation of a Multi-domain Protein: A Coagulation Mechanism Governs Aggregation of a Model IgG1 Antibody Under Weak Thermal Stress. Protein Sci. 2010, 19 (2), 279-290.
26. Lacher, N. A.; Roberts, R. K.; He, Y.; Cargill, H.; Kearns, K. M. Development, Validation, and Implementation of Capillary Gel Electrophoresis as a Replacement for SDS-PAGE for Purity Analysis of IgG2 mAbs. J. Sep. Sci. 2010, 33 (2), 218-227.
27. Tarazona, M. P.; Saiz, E. Combination of SEC=MALS Experimental Procedures and Theoretical Analysis for Studying the Solution Properties of Macromolecules. J. Biochem. Biophys. Method. 2003, 56 (1-3), 95-116. (Pubitemid 36776596)